Diagnostic Biochemistry By Professor: Ali Abdul Hussein S. AL-Janabi Dept. of Clinical laboratories, Collage of AMS, University of Karbala, Iraq 2014-

Slides:

Advertisements

Similar presentations

Case # 1 Dr. Laura Lamps A 32 year old Caucasian man presented to the Hepatology Clinic after he was found to have elevated transaminases during a routine.

Advertisements

Group D Florendo-Gaspar.  Tests based on detoxification and excretory functions  Tests that measure biosynthetic function  Coagulation factors  Other.

AN INTRODUCTION TO LABORATORY TESTS. Aim - introduction to laboratory tests of clinical and diagnostic importance - biochemistry and haematology Aim -

BMP (Basic Metabolic Panel)

Liver Function Tests (LFTs)

1 CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FOUR Dr. Essam H. Aljiffri.

AST, ALT & ALP Lab. 5.

How to Interpret Your Lab Results Presented by Pat Hogan, ARNP, AAHIVS Group Health Cooperative.

Abnormal LFTs Liver disease is often asymptomatic Deranged LFTs may be the only sign of a serious underlying liver disease Or they may be nothing wrong!

275 BCH Miss Tahani Al-Shehri

(clinical biochemistry of enzymes)

DESCRIPTION  Alkaline phosphatase (ALP) (EC ) catalyzes the hydrolysis of phosphate esters in an alkaline environment, resulting in the formation.

Liver function tests Lecture 3.

Chapter 15 Bilirubin and Urobilinogen

Hormones. Hormones: compounds which are synthesized and secreted from special secretory or endocrine glands.

Downloaded from Slide 1 Ezetimibe Coadministered with Atorvastatin in Patients with Hypercholesterolemia and Coronary Heart.

Interpreting Your Biopsy and Lab Results

Midterm Exam Thursday, May 3, 3PM or by arrangement pick up labs on Tuesday at 2PM in 129 MI Topics: Intro to Nutrition Assessment Anthropometric Assessment.

Serum biochemical parameters (ALT) (AST) assay Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015.

Section IV. Routine and Optional Laboratory Tests for the Investigation of Patients with Hypertension 2015 Canadian Hypertension Education Program Recommendations.

Cellular Biochemistry and Metabolism (CLS 333 ) Dr. Samah Kotb Nasr Eldeen Serum biochemical parameters (ALT) (AST) assay.

Pathophysiology. Maximum therapeutic dose: - 4g in adults - 90mg/kg in children Toxicity is with single ingestion of 150 mg/kg or ~7-10 g (adult)

Enzymes AST, ALT & ALP Lab. 6.

Overview of Clinical Chemistry

Welcome Advanced Clinical Chemistry BISC Dr Atef Masad PhD Biomedicine Uinited Kingdom Advanced Clinical Chemistry BISC 6360.

This initiative of SMARTVIZ MARKETING PVT. LTD. is started keeping in mind the health issues and nutritional gap in an individual, thus creating its.

Pre- analytic Analytic Post- analytic  S pecimen collection  Specimen transport  Specimen quality  Result accuracy  Clerical.

Table 1. Clinical characteristics of subjects Mean ± s.d. n1363 Age (years)55.6 ± 14.1 Genders, % Males49.1 Females50.9 Diabetes, %44.9 Hypertension, %14.0.

Clinical Laboratory Review for Toxicology

Basic biochemical analyses. What is biochemical testing? Biochemical testing looks at the levels of specific substances and enzymes that are produced.

Lab # 2 Liver Function Tests (LFTs) ALT&AST T.A. Bahiya M. Osrah.

Khadija Balubaid KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (BIOC 416) 2013 Liver Function profile (LFT) Enzymes.

Date of download: 5/30/2016 From: Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized,

REFERENCE VALUES OR NORMAL VALUES GIVEN FOR ANY TEST SHOULD ONLY BE CONSIDERED? GUIDELINES.

prepared by Dr. Akaber Tarek Biochemistry Department Clinical Chemistry prepared by Dr. Akaber Tarek Biochemistry Department Clinical Chemistry prepared.

Human Biology By Professor: Ali Abdul Hussein S. AL-Janabi Dept. of Clinical laboratories, Collage of AMS, University of Karbala, Iraq

1-urin and stool findings: hemolyticobstructivehepatocellular Urine bilinogenincreasedabsentMay increase or decrease Faeces stercobilinincreaseddecreasedDecreased.

Lab (2): Liver Function profile (LFT)

Medical Biology By Professor: Ali Abdul Hussein S. AL-Janabi Dept. of Clinical laboratories, Collage of AMS, University of Karbala, Iraq

Laboratory tests in digestive systema Klinika Gastroenterologii Dr n. med. Małgorzata Pujanek.

Revision for Clinical Biochemistry Lab

Anemia. Normocytic Macrocytic Microcytic Production Destruction Loss.

Liver Function Tests (LFTs)

Betty Sawyer, M Ed RD LD Registered Clinical Dietitian

Liver Function Tests (LFTs)

Table 1. Serum Biomarkers

Lab (2): Liver Function profile (LFT)

Revision for Clinical Biochemistry Lab

Interpretation Of LAB Data

GYNAECOLOGY SCREENING 1

Basic laboratory testing

Protocol for the management of adult patients with DKA

Basic laboratory testing

Protocol for the management of adult patients with HHS

Rational Order of Laboratory Tests in Cardiovascular Diseases

Protocol for the management of adult patients with HHS

Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.

Gastroenterology & Nutrition Block Biochemistry Department

Protocol for the management of adult patients with DKA

Common Laboratory Tests

Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.

Response to abnormal liver blood tests.

Effects of pterosin A on serum levels of lipid, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), and alanine aminotransferase (ALT)

Determination of plasma enzymes

Supplementary table 1 Supplementary table 1. Serum biochemistry data and hepatic lipid profiles after drinking water or 20% ethanol for 4 weeks Parameters.

LINDA S. SNYDER, M.D., RUSSELL I. HEIGH, M.D., MONTE L. ANDERSON, M.D.

Protocol for the management of adult patients with DKA

Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia Anna.

© The Author(s) Published by Science and Education Publishing.

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Presentation transcript:

Diagnostic Biochemistry By Professor: Ali Abdul Hussein S. AL-Janabi Dept. of Clinical laboratories, Collage of AMS, University of Karbala, Iraq

Lecture 1- Purpose of Testing 1.Test Phases 2.Pretest interventions 3.Intratest interventions 4.Posttest interventions 5.Interfering factors: 6. Factors related to laboratory 7.Factors related to patient 8.Preparation of patient for test

Lecture 2- blood sugar 1.Diabetes testing- Blood glucose or blood sugar 2.Test types 3.Reference values 4.Hyperglycemia 5.Hypoglycaemia 6.Interfering factors: 7. Elevated glucose 8.Decreased glucose 9.Pretest patient care 10.Posttest patient care

Lecture 3- Liver function tests: Bilirubin 1.Cause of level Rise 2.Types of bilirubin 3.Increase indicators 4.Main aim of test 5.Reference values (Adult) 6.Clinical implications 7.Elevated indirect (unconjugated) bilirubin 8.Elevated direct (conjugated) bilirubin levels 9.Interfering factors 10.Interventions : A- Pretest patient care 11.B- Posttest patient care

Lecture 4- Alanine Transaminase (ALT) 1.Test aim 2.Reference values 3.Clinical implications: Increased ALT levels 4.Decreased ALT levels 5.Interfering factors 6.Interventions: Pretest patient care 7.Posttest patient care

Lecture 5- Aspartate Transaminase (AST) 1.Aim of test 2.Reference values 3.Clinical implication: Increase 4.Decrease 5.Interfering factors 6.Interventions: Pretest patient care 7.Posttest patient care 8.AST/ALT comparison

Lecture 6- Alkaline Phosphatase (ALP) 1.Functions 2.Types and Specificity 3.Aim of test 4.References values 5.Clinical implications : Increase levels (Liver diseases) 6.Increase levels (Bone diseases) 7.Decrease levels 8.Interfering factors 9.Interventions: Pretest patient care 10.Posttest patient care

Lecture 7- Lipid Profile: Cholesterol 1.Aim of Test 2.Reference values 3.Clinical implications : Increased levels (hypercholesterolemia) 4.Decreased levels (hypocholesterolemia) 5.Interfering factors 6.Interventions: Pretest patient care 7.Posttest patient care

Lecture 8- High-Density Lipoprotein Cholesterol (HDL-C) 1.Aim of test 2.Reference values 3.Clinical implications : Increase levels 4.Decrease levels 5.Interfering factors 6.Interventions : Pretest patient care 7.Posttest patient care

Lecture 9-Triglycerides 1. Aim of test 2.Normal Ranges 3.Clinical implications: Increase levels 4.Decrease levels 5.Interfering factors 6.Interventions: Pretest patient care 7.Posttest patient care

Lecture 10- Kidney function tests: Blood Urea Nitrogen (BUN) 1.Aim of Test 2.Pathway of Urea 3.Reference Ranges 4.Clinical implications: Increase levels 5.Decrease levels 6.Interfering factors 7.Interventions : Pretest patient care 8.Posttest patient care

Lecture 11- Creatinine 1.Aim of Test 2.Reference Ranges 3.Clinical implications: Increase levels 4.Decrease levels 5.Interfering factors 6.Interventions : Pretest patient care 7.Posttest patient care